Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteTHE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH
BOUNDARY HOUSE, 91 CHARTERHOUSE STREET, LONDON, EC1M 6HR
Buy Report - £20
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH
Private Ltd By Guarantee w/o Share Cap
Active - Accounts Filed
13 October 1969
72190 Other research and experimental development on natural sciences and engineering - Other research and experimental development on natural sciences and engineering
Available to 08 Apr 2025. Next accounts due by 30 Jun 2026
Is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Professor Paul Emery | Director | ||
| Dr Edith Margarethe Hessel | Director | ||
| Dr Anthony Wood | Director | ||
| Professor Paul Peter Tak | Director | ||
| Mr Joseph Henry Cronly | Director | ||
| Mrs Harsha Patel | Director | ||
| Mrs Hazel Fiona Middleton | Company Secretary | ||
| Professor Michael Alexander Patton | Director | ||
| Mr Christopher John Coombe | Director | ||
| Dr Paul Wayne Satchell | Director | ||
| Mr Richard Kenneth Punt | Director | ||
| Mr Mark Stefano Dighero | Director |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
1
Total Satisfied
0
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| J.p. Morgan Bank Luxembourg S.a. | OUTSTANDING |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £1,706,000.00 | £1,420,000.00 | £1,797,000.00 | £3,095,000.00 | £1,906,000.00 |
| Net Worth | £301,908,000.00 | £271,903,000.00 | £279,118,000.00 | £306,428,000.00 | £276,277,000.00 |
| Total Current Liabilities | £13,429,000.00 | £14,109,000.00 | £10,355,000.00 | £9,280,000.00 | £9,463,000.00 |
| Total Current Assets | £2,178,000.00 | £2,788,000.00 | £2,376,000.00 | £3,762,000.00 | £2,709,000.00 |
Frequently Asked Questions about THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH
Detailed answers about THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH, including incorporation, status, business activity, and accounts information.
When was THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH founded?
THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH was officially incorporated on 13 October 1969 and is registered under company number 00963832. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH?
Private Ltd By Guarantee w/o Share Cap. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH?
THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH do?
THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH operates in the following sector: 72190 Other research and experimental development on natural sciences and engineering - Other research and experimental development on natural sciences and engineering . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH's registered address?
The registered office address of THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH is 91-93, Charterhouse Street, London, Islington, EC1M 6HR. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH financially stable?
Based on the latest accounts up to 08 Apr 2025, THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Jun 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.